733 related articles for article (PubMed ID: 29562314)
21. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.
Beijer D; Kim HJ; Guo L; O'Donovan K; Mademan I; Deconinck T; Van Schil K; Fare CM; Drake LE; Ford AF; Kochański A; Kabzińska D; Dubuisson N; Van den Bergh P; Voermans NC; Lemmers RJ; van der Maarel SM; Bonner D; Sampson JB; Wheeler MT; Mehrabyan A; Palmer S; De Jonghe P; Shorter J; Taylor JP; Baets J
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291734
[TBL] [Abstract][Full Text] [Related]
22. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
23. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
24. Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis.
D'Alton S; Altshuler M; Lewis J
RNA; 2015 Aug; 21(8):1419-32. PubMed ID: 26089325
[TBL] [Abstract][Full Text] [Related]
25. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.
Salapa HE; Hutchinson C; Popescu BF; Levin MC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1214-1224. PubMed ID: 32608162
[TBL] [Abstract][Full Text] [Related]
26. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS.
Shiga A; Ishihara T; Miyashita A; Kuwabara M; Kato T; Watanabe N; Yamahira A; Kondo C; Yokoseki A; Takahashi M; Kuwano R; Kakita A; Nishizawa M; Takahashi H; Onodera O
PLoS One; 2012; 7(8):e43120. PubMed ID: 22900096
[TBL] [Abstract][Full Text] [Related]
27. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
28. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
Fallini C; Bassell GJ; Rossoll W
Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
[TBL] [Abstract][Full Text] [Related]
30. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells.
Appocher C; Mohagheghi F; Cappelli S; Stuani C; Romano M; Feiguin F; Buratti E
Nucleic Acids Res; 2017 Jul; 45(13):8026-8045. PubMed ID: 28575377
[TBL] [Abstract][Full Text] [Related]
31. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
32. An acetylation switch controls TDP-43 function and aggregation propensity.
Cohen TJ; Hwang AW; Restrepo CR; Yuan CX; Trojanowski JQ; Lee VM
Nat Commun; 2015 Jan; 6():5845. PubMed ID: 25556531
[TBL] [Abstract][Full Text] [Related]
33. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer RC; Chami AA; de Assis DR; Vourc'h P; Andres CR; Corcia P; Lanznaster D; Blasco H
Brain; 2019 May; 142(5):1176-1194. PubMed ID: 30938443
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of trans-active response DNA-binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing.
Wu R; Zhou D; Shen X; Chen F; Liu F; Gu J
J Neurochem; 2021 Aug; 158(3):766-778. PubMed ID: 34107054
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.
Moujalled D; James JL; Yang S; Zhang K; Duncan C; Moujalled DM; Parker SJ; Caragounis A; Lidgerwood G; Turner BJ; Atkin JD; Grubman A; Liddell JR; Proepper C; Boeckers TM; Kanninen KM; Blair I; Crouch PJ; White AR
Hum Mol Genet; 2015 Mar; 24(6):1655-69. PubMed ID: 25410660
[TBL] [Abstract][Full Text] [Related]
36. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.
Koike Y; Pickles S; Estades Ayuso V; Jansen-West K; Qi YA; Li Z; Daughrity LM; Yue M; Zhang YJ; Cook CN; Dickson DW; Ward M; Petrucelli L; Prudencio M
PLoS Biol; 2023 Mar; 21(3):e3002028. PubMed ID: 36930682
[TBL] [Abstract][Full Text] [Related]
37. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
[TBL] [Abstract][Full Text] [Related]
38. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis.
Calini D; Corrado L; Del Bo R; Gagliardi S; Pensato V; Verde F; Corti S; Mazzini L; Milani P; Castellotti B; Bertolin C; Sorarù G; Cereda C; Comi GP; D'Alfonso S; Gellera C; Ticozzi N; Landers JE; Ratti A; Silani V;
Neurobiol Aging; 2013 Nov; 34(11):2695.e11-2. PubMed ID: 23827524
[TBL] [Abstract][Full Text] [Related]
39. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
40. A role for SUMOylation in the Formation and Cellular Localization of TDP-43 Aggregates in Amyotrophic Lateral Sclerosis.
Maurel C; Chami AA; Thépault RA; Marouillat S; Blasco H; Corcia P; Andres CR; Vourc'h P
Mol Neurobiol; 2020 Mar; 57(3):1361-1373. PubMed ID: 31728929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
